NIAID

NIAID

Health International
The first HIV vaccine efficacy study to launch anywhere in seven years is now testing whether an experimental vaccine regimen safely prevents HIV infection among South African adults. ...
0

Top News Health
The buildup of soft plaque in arteries that nourish the heart is more common and extensive in HIV-infected men than HIV-uninfected men, a new study shows. ...
0

Top News Health
Scientists Wednesday reported initial results from humans on the safety and tolerability of a novel strategy to curb HIV disease by removing key cells. ...
0

NIAID Awards 14 Grants for HIV Vaccine Research
The grants were awarded under the Innovation for HIV Vaccine Discovery initiative, which is expected to receive up to $34.8 million over the next four years. ...
0

HIV Superinfection in Uganda More Common Than Originally Thought, New Study
HIV superinfection in Uganda may be more common than previously thought, study finds. ...
0